focus -WSS

focus

author：fashion 2025-10-01 04:13:25 - browse：992

Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT — Adobe

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How doctors and nurses shape Google's AI

entertainment

WSS

Akero's treatment for NASH falls short in cirrhosis study

Insmed lung disease drug hits target in key Phase 3 trial

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Medicare to cover more brain scans related to Alzheimer’s drugs

Humana CEO Bruce Broussard to step down in 2024

entertainment

focus

focus

How to save PrEP access — and even expand it

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

State Dept. review finds Biden bears some blame for Afghanistan failures

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Psychedelics group wrestles with new pharma identity

Adam's Biotech Scorecard: Do Sarepta's exon

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Akero's treatment for NASH falls short in cirrhosis study

The high cost of giving birth even with insurance

Scientists successfully use ultrasound imaging to map brain activity

focus

STAT Readout: Today's biotech news includes Sana and Amylyx

Stigma and the return of syphilis

How doctors and nurses shape Google's AI

Addiction doctors spar with methadone clinics over legislation

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

European regulators consider appeal over Amylyx ALS drug

focus

explore

entertainment

hotspot